The device was not returned for analysis therefore the allegations against this device cannot be confirmed.There were no manufacturing rejects or anomalies of this event type recorded in the device history records.The introducer passed all in-process and qa final inspections before shipping to the customer, including visual, mechanical and dimensional tests.A review of complaints against this lot number identified no additional similar events.Per the quality assurance abiomed introducer sheath in-process and final inspection procedure it instructs the operators to use 10x magnification for visual inspection unless specified otherwise.Visual inspection includes verify the hub is smooth, has no cracks, no short shots, sinking or unfilled areas, check for foreign material, check hub shape, french size embossed on hub, and for excessive flash.Using 10x magnification look down into hub for irregularities; verify no splitting at break lines and a smooth transition between sheath and hub on inside of hub.Verify score lines are spaced evenly around the circumference of sheath tube; look down into the hub and verify score lines on sheath align with break line of the hub.Measure dimensions; verify sideport opening diameter using pin gauges; visually inspect the sideport hole is without any flash or blockage.Measure usable sheath length after over molding from end of hub to end of tube, using metric ruler.Verify i.D.And inner clearance of sheath by inserting a calibrated pin gauge into hub end, all the way through to the tip.Use go-no-go gauge for o.D.Verification; verify the full length passes through the gauge.Using 10x magnification, verify the tip is round, no flash, no splitting, cracks or other damages.Insert a tipped dilator through the tipped sheath and check if dilator inserts without excessive force or obstruction.With the naked eye, inspect where the sheath and dilator meet and check gap and that a smooth transition is present.Measure usable sheath length after tipping; from end of hub to tip of tube, using metric ruler.Measure tip i.D.Of sheath using pin gauge.Visual inspection with naked eye, ensure parts are free of kinks, cracks, splits, sinks, excessive flash, loose/embedded foreign material or any other damages.Verify split caps are properly placed and secured onto sheath hub and free of cracks/damages or excessive adhesive.Perform pressure and vacuum leak test and perform occlusion test.Assembly fit check, insert dilator into sheath, lock and unlock dilator hub lock nut for verification of proper fit; verify no gaps between sheath tip and dilator.The abiomed adelante s2 hemostatic peel-away introducer system with infusion sideport instructions for use (ifu) lists the following adverse effects and possible complications: air embolism, bleeding, hematoma formation and vessel damage.Precaution - aspiration and saline flushing of the sheath, dilator, and valve should be performed to help minimize the potential for air embolism and clot formation.Also, the ifu instructs the user to aspirate all air from the sheath valve assembly by using a syringe connected to the sideport.Flush the sheath with 5 cc of saline immediately before peeling the sheath away in order to minimize back bleeding since the device was not returned, a root cause could not be determined.Based on the investigation, a capa is not required as findings did not identify a design, labeling or manufacturing non-conformity.In addition, there was no new failure mode identified and the risk remains acceptable.The event will be re-evaluated if additional information becomes available.Oscor will continue to monitor this event type and risk.Oscor inc., is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc., which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor, inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor, inc., or its employees, that the report constitutes an admission that the device, oscor, inc., or its employees caused or contributed to the event described in this report.
|